Login / Signup

A neurodevelopmental disorder mutation locks G proteins in the transitory pre-activated state.

Kevin M KnightBrian E KrummNicholas J KapolkaW Grant LudlamMeng CuiSepehr ManiIya PrytkovaElizabeth G ObarowTyler J LefevreWenyuan WeiNing MaXi Ping HuangJonathan F FayNagarajan VaidehiAlan V SmrckaPaul A SlesingerDiomedes E LogothetisKirill A MartemyanovBryan L RothHenrik G Dohlman
Published in: Nature communications (2024)
Many neurotransmitter receptors activate G proteins through exchange of GDP for GTP. The intermediate nucleotide-free state has eluded characterization, due largely to its inherent instability. Here we characterize a G protein variant associated with a rare neurological disorder in humans. Gα o K46E has a charge reversal that clashes with the phosphate groups of GDP and GTP. As anticipated, the purified protein binds poorly to guanine nucleotides yet retains wild-type affinity for G protein βγ subunits. In cells with physiological concentrations of nucleotide, Gα o K46E forms a stable complex with receptors and Gβγ, impeding effector activation. Further, we demonstrate that the mutant can be easily purified in complex with dopamine-bound D2 receptors, and use cryo-electron microscopy to determine the structure, including both domains of Gα o , without nucleotide or stabilizing nanobodies. These findings reveal the molecular basis for the first committed step of G protein activation, establish a mechanistic basis for a neurological disorder, provide a simplified strategy to determine receptor-G protein structures, and a method to detect high affinity agonist binding in cells.
Keyphrases